A groundbreaking gene therapy has shown it can slow the progression of Huntington's disease by 75% in a small clinical trial. This one-time treatment could reshape the future for patients with this rare brain disorder.
Scientists from University College London have made a groundbreaking discovery that could slow the progression of Huntington’s disease. A new gene therapy, AMT-130, shows promising results in clinical trials, potentially changing lives forever.
In a groundbreaking announcement, gene therapy company uniQure revealed an experimental treatment that has slowed the progression of Huntington's disease. Although still in early testing, this could signal new hope for patients battling this devastating condition.
In a remarkable turn of events, 8-year-old Nathaniel Schumann, who was nonverbal, began to speak in full sentences just two weeks after starting a clinical trial for an autism treatment. This development raises hopes for many families.
Elissa Kalver, diagnosed with HER2-positive metastatic breast cancer at 34, shares her inspiring journey through aggressive treatments, clinical trials, and living life to the fullest despite her diagnosis.
A recent study reveals that high sucralose intake may hinder immunotherapy effectiveness in cancer patients. Discover how arginine supplements could be the key to improving outcomes.
A groundbreaking clinical trial reveals that a single dose of LSD can alleviate symptoms of generalized anxiety disorder for months. Discover how this study could change the landscape of mental health treatment.
A groundbreaking study reveals that beta blockers may not benefit heart attack patients with preserved heart function. Discover the surprising results that could change treatment protocols.
A historic pig lung transplant into a brain-dead human patient lasted nine days, showcasing the potential and challenges of xenotransplantation. While the patient faced organ rejection, this experiment opens new avenues in medical science.
Eli Lilly's new obesity pill, orforglipron, faces tough competition but could disrupt the weight loss market. Despite underwhelming trial results, analysts see potential for success due to manufacturing advantages and pricing strategies.
